The EFPIA SME Financing working group is currently gathering feedback from small European biopharmaceutical companies operating in Europe in order to map the financial environment they are evolving in. This mapping will help raise awareness among European decision makers about numerous obstacles that small companies are facing in Europe and that are hampering innovation. It will also help propose solutions to enhance the European biopharmaceutical funding ecosystem for SMEs and small mid-caps (public and private).

By spending ~10 minutes of your time answering our survey, you will help us develop a white paper aimed at serving European biopharmaceutical SMEs' best interests.